Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
IRCT |
Last refreshed on:
|
22 February 2018 |
Main ID: |
IRCT2016050127707N1 |
Date of registration:
|
2016-08-16 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Efficacy of laser therapy in extrimity wart
|
Scientific title:
|
Efficacy and safety of nd:yag laser therapy with cryotherapy in extremities(hand,foot) wart |
Date of first enrolment:
|
2016-01-21 |
Target sample size:
|
63 |
Recruitment status: |
Complete |
URL:
|
http://en.irct.ir/trial/22640 |
Study type:
|
interventional |
Study design:
|
Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Iran (Islamic Republic of)
| | | | | | | |
Contacts
|
Name:
|
Behzad Iranmanesh
|
Address:
|
The SBMU SRC (Skin Research Center), Shohada-E- Tajrish Educational Hospital, Qods Sq., Tehran, Iran, Islamic Republic Of
Tehran
Iran (Islamic Republic of) |
Telephone:
|
+98 21 2676 1435 |
Email:
|
behzad_ariiana@yahoo.com mgheisari@sbmu.ac.ir |
Affiliation:
|
Skin Research Center |
|
Name:
|
Dr.Mehdi Gheisari
|
Address:
|
Skin Research Center, Shohada-E- Tajrish Educational Hospital, Qods Sq. ,Tehran, Iran Tehran
Tehran
Iran (Islamic Republic of) |
Telephone:
|
+98 913 151 9705 |
Email:
|
mgheisari@sbmu.ac.ir |
Affiliation:
|
Skin Research Center |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Inclusion criteria:bilateral warts on extremities(upper or lower)
Exclusion criteria:immunodeficiency state(diabetes mellitus;alcohol abuse)
congenital immunodeficiency disorders; hematologic malignancy; drug history of immunnomodulator agent during 4 weeks past;
drug history of anti viral agent during 2 weeks past;pregnancy;breast feeding.
Exclusion criteria:
Age minimum:
no limit
Age maximum:
no limit
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Anogenital (venereal) warts
|
wart. Anogenital (venereal) warts
|
Intervention(s)
|
The patients with bilateral extrimitie's warts will join to study,and all of their demoghraphic datas and properties(site,diameter) of warts and association are saved .
after preparation and anesthesia one side treat with long pulsed nd;yag laser(laser optek) with setting , fluence: 200 j/cm^2 , spot size :3mm, duration:20ms? wave length: 1064 nm. in every session with 3 shots circular guide.
all patients follow and evaluate 3 months after the last session, index of treatment is treated lesion devided into tatol lesions.
|
Intervention 1: The patients with bilateral extrimitie's warts will join to study,and all of their demoghraphic datas and properties(site,diameter) of warts and association are saved . after preparation and anesthesia one side treat with long pulsed nd;yag laser(laser optek) with setting , fluence: 200 j/cm^2 , spot size :3mm, duration:20ms? wave length: 1064 nm. in every session with 3 shots circular guide. all patients follow and evaluate 3 months after the last session, index of treatment is treated lesion devided into tatol lesions. Intervention 2: The patients with bilateral extrimitie's warts will join to study,and all of their demoghraphic datas and properties(site,diameter) of warts and association are saved . after preparation and anesthesia one side treat with cryo therapy with liquid nitrogen -196cellsius and 2mm margin with open spray every 2 weeks bye 3 times.
|
The patients with bilateral extrimitie's warts will join to study,and all of their demoghraphic datas and properties(site,diameter) of warts and association are saved . after preparation and anesthesia one side treat with cryo therapy with liquid nitrogen -196cellsius and 2mm margin with open spray every 2 weeks bye 3 times.
|
Treatment - Other
|
Primary Outcome(s)
|
Diameter of primary lesion on centimeters. Timepoint: 2weeks. Method of measurement: ruller.
|
Secondary Outcome(s)
|
Blister and ulser formation. Timepoint: 2 weeks. Method of measurement: physical examination.
|
Source(s) of Monetary Support
|
Shahid Beheshti University of Medical Science-Skin Research Center.
|
Ethics review
|
Status: Approved
Approval date:
Contact:
shahid beheshti medical univwersity
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|